Innovent and Coherus Strike Licensing Agreement for Avastin Biosimilar

Innovent and Coherus Strike Licensing Agreement for Avastin Biosimilar

Submitted by admin on January 16, 2020 - 11:14pm
Source: 
BioSpace
News Tags: 
China
Innovent Biologics
Coherus Biosciences
biosimilars
Avastin
Headline: 
Innovent and Coherus Strike Licensing Agreement for Avastin Biosimilar
snippet: 

China’s Innovent Biologics forged a licensing agreement with biosimilar-focused Coherus BioSciences to commercialize Innovent's biosimilar candidate to Avastin (bevacizumab) in the United States and Canada.

Do Not Allow Advertisers to Use My Personal information